Molecular Profiles Enhances Specialist Pharmaceutical Patent Litigation Support With New Appointment, UK

Main Category: Pharma Industry / Biotech Industry
Article Date: 30 Nov 2007 - 2:00 PDT

email to a friend   printer friendly   opinions  

Molecular Profiles, a global leader in the provision of innovative contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors worldwide, announces the appointment of Dr. Rob Whittock as Associate Director of Materials Characterisation. Based in Nottingham, he will provide technical direction and leadership to the materials characterisation team and support independent experts across the UK, Europe and USA; and clients' scientific staff, Patent Attorneys and in-house Patent Counsel.

Dr. Rob Whittock holds a PhD in Physical Organic Chemistry and previously worked as a Senior Scientist at AstraZeneca, where he gained a wealth of experience in pharmaceutical R&D, particularly in solid state characterisation (Polymorphism) and the developability assessment of new candidate drugs. In addition to his interest in solid state characterization he has a strong interest in intellectual property law, and has undertaken a post graduate diploma in Law at Nottingham Law School and the Bar Vocational Course at BPP Law School, London.

Molecular Profiles' services can be broadly categorised into three key areas: formulation support (including pre-formulation and product R&D); rapid problem solving (during pre-formulation right through to manufacturing); and patent and litigation support. Molecular Profiles have a range of expert witnesses who lead multidisciplinary teams that can attest to international experience of deposition and trial testimony in support of litigation issues.

"Molecular Profiles offers me the opportunity to combine my interests in solid state characterisation and intellectual property law, and apply my knowledge and experience to real world pharmaceutical patent litigation issues", comments Dr. Rob Whittock. "The materials characterization team at Molecular Profiles is in a very fortunate position in having one the World's best equipped solid state characterization laboratories".

Dr. Rob Whittock will take a leading role in driving the generation of publications and presentations at conferences on behalf of Molecular Profiles and will be speaking at the forthcoming IQPC 3rd annual conference, "IP Strategies for Crystalline Forms" which will be held on the 5th and 6th December 2007 at the Thistle Hotel Marble Arch, London.

In April 2007, Molecular Profiles were awarded a Queen's Award for Enterprise in the Continuous Innovation and Development category. The award recognised their range of services as one of the UK's most innovative during 2007.

"Over the years we have grown organically, by reinvesting in the latest technology, developing new analytical methodologies and expanding our services", comments Dr. Nikin Patel, CEO, Molecular Profiles. "Our services and technology are extremely innovative and we are delighted to have Rob playing an important part in the company's future structure, processes and procedures."

More information about Molecular Profiles' award-winning services is available at http://www.molprofiles.co.uk

About Molecular Profiles

Molecular Profiles is a leader in the provision of innovative contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors worldwide. The company is a recipient of a Queen's Award for Enterprise in the Continuous Innovation and Development category. The award saw the company and its complete range of services recognised as one of the UK's most innovative during 2007. The services include nanoscreening technology for predicting the ease of development of a new medicine, a deformulation service for identifying problems with a product down to the nanoscale, and advanced imaging for viewing and optimising the internal structure of products.

Molecular Profiles

• Additional
• References
• Citations